The company received USFDA approval for Dextromethorphan Polistirex extended-release oral suspension, with planned launch in ...

Royalty Pharma Plc (NASDAQ:RPRX) is one of the most undervalued biotech stocks to buy right now. Royalty Pharma Plc (NASDAQ:RPRX) announced on April 17 that its board of directors approved the payment ...

With respect to the 2026 RSU grants to U.S. employees, RSUs vest annually in equal tranches over three years, from April 19, ...

More pharma companies are launching direct-to-consumer drug platforms and the rise of these self-pay services could improve ...

Ohtuvayre® (ensifentrine) helped improve lung function in Chinese adult patients in in data published in peer reviewed ...

Vertex Pharmaceuticals' business will suffer if other drugmakers launch competing cystic fibrosis drugs. Despite this threat, ...

Several of pharma’s top leaders scored large pay bumps last year, including two new chiefs who joined the “$30 million club.” ...

Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...

When researching pharma companies, investors might start by reviewing the drug pipeline. Companies constantly need to be ...

SAM Pharmaceutical Limited has taken a major step to strengthen drug manufacturing in Nigeria with the inauguration of a state-of-the-art pharmaceutical plant ...

FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to ...